Fund Holdings — Altium Capital Management LLC

Total Portfolio Value:
$34.43M
Total Bought:
$713.0K
Total Sold:
$287.63M
Net Transaction:
-$286.91M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Zevra Therapeutics, Inc.(ZVRA)1,850,0001,287,333-562,667$15.43M$9.64M28.00%-$5.79M
Evolus, Inc.(EOLS)685,000296,193-388,807$7.56M$3.56M10.35%-$4.00M
Xtant Medical Holdings, Inc.(XTNT)7,415,4137,252,998-162,415$3.29M$3.41M9.90%+$123.9K
Avadel Pharmaceuticals Plc452,475419,131-33,344$4.76M$3.28M9.53%-$1.47M
Contineum Therapeutics, Inc.CL A(CTNM)334,000303,857-30,143$4.89M$2.12M6.16%-$2.77M
Profound Medical Corp.(PROF)485,000360,589-124,411$3.64M$2.10M6.09%-$1.54M
Xenon Pharmaceuticals Inc.(XENE)288,00060,251-227,749$11.29M$2.02M5.87%-$9.27M
Essa Pharma Inc1,428,0001,050,369-377,631$2.56M$1.66M4.82%-$896.5K
Skye Bioscience, Inc.(SKYE)1,139,000904,865-234,135$3.22M$1.44M4.18%-$1.78M
Alpha Cognition Inc. Common Stock(ACOG)275,000177,416-97,584$1.62M$897.7K2.61%-$722.0K
Rezolute, Inc.(RZLT)1,694,000303,949-1,390,051$8.30M$881.5K2.56%-$7.42M
Nektar Therapeutics(NKTR)3,000,0001,051,379-1,948,621$2.79M$714.9K2.08%-$2.08M
Anteris Technologies Global Corp.(AVR)737,000168,589-568,411$4.11M$613.7K1.78%-$3.50M
Larimar Therapeutics, Inc.(LRMR)505,000273,204-231,796$1.95M$587.4K1.71%-$1.37M
Promis Neurosciences Inc581,395574,248-7,147$551.0K$399.4K1.16%-$151.7K
enVVeno Medical Corporation(NVNO)310,000123,256-186,744$936.2K$324.2K0.94%-$612.0K
Intelligent Bio Solutions In0149,252+149,252$0$214.9K0.62%+$214.9K
Karyopharm Therapeutics Inc.(KPTI)049,333+49,333$0$184.5K0.54%+$184.5K
Sharps Technology Inc04,044,149+4,044,149$0$110.4K0.32%+$110.4K
Logicmark Inc05,395,308+5,395,308$0$106.8K0.31%+$106.8K
Sunshine Biopharma, Inc.(SBFM)050,466+50,466$0$96.4K0.28%+$96.4K
SRX Global Inc.(SRXH)118,45938,984-79,475$278.4K$67.1K0.19%-$211.3K
Adma Biologics Inc1,395,0000-1,395,000$23.92M$0—-$23.92M
Alphatec Holdings, Inc.(ATEC)264,5620-264,562$2.43M$0—-$2.43M
Anaptysbio Inc18,3260-18,326$242.6K$0—-$242.6K
argenx SEADR(ARGX)10,0000-10,000$6.15M$0—-$6.15M
Arrowhead Pharmaceuticals, Inc.(ARWR)230,2570-230,257$4.33M$0—-$4.33M
Bicycle Therapeutics PlcADS40,3520-40,352$564.9K$0—-$564.9K
Biohaven Ltd.(BHVN)250,0000-250,000$9.34M$0—-$9.34M
Capricor Therapeutics, Inc.(CAPR)714,0000-714,000$9.85M$0—-$9.85M
Catalyst Pharmaceuticals Inc255,0000-255,000$5.32M$0—-$5.32M
Cellectar Biosciences, Inc.(CLRB)215,0000-215,000$64.3K$0—-$64.3K
COMPASS Pathways plcADS(CMPS)1,424,4000-1,424,400$5.38M$0—-$5.38M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)385,0000-385,000$4.54M$0—-$4.54M
CytomX Therapeutics, Inc.(CTMX)467,4910-467,491$481.5K$0—-$481.5K
Edwards Lifesciences Corp165,0000-165,000$12.21M$0—-$12.21M
Establishment Labs Holdings Inc.(ESTA)305,0000-305,000$14.05M$0—-$14.05M
Endeavour Silver Corp.(EXK)100,0000-100,000$5.62M$0—-$5.62M
Fulcrum Therapeutics, Inc.(FULC)111,8120-111,812$525.5K$0—-$525.5K
Glaukos Corporation(GKOS)40,0000-40,000$6.00M$0—-$6.00M
ImmunityBio, Inc.(IBRX)1,060,0000-1,060,000$2.71M$0—-$2.71M
Insmed Incorporated(INSM)132,0000-132,000$9.11M$0—-$9.11M
Intra-Cellular Therapies Inc75,0000-75,000$6.26M$0—-$6.26M
Karyopharm Therapeutics Inc.(KPTI)740,0000-740,000$500.5K$0—-$500.5K
Keros Therapeutics, Inc.(KROS)175,0000-175,000$2.77M$0—-$2.77M
Lexeo Therapeutics, Inc.(LXEO)405,0000-405,000$2.66M$0—-$2.66M
Merit Medical Systems, Inc.(MMSI)100,0000-100,000$9.67M$0—-$9.67M
OnKure Therapeutics, Inc.CL A(OKUR)218,3860-218,386$1.88M$0—-$1.88M
ORIC Pharmaceuticals, Inc.(ORIC)355,0000-355,000$2.86M$0—-$2.86M
Perspective Therapeutics, Inc.(CATX)92,2240-92,224$294.2K$0—-$294.2K
Proqr Thrapeutics N VSHS EURO
SHS EURO
575,0000-575,000$1.52M$0—-$1.52M
Pulmonx Corporation(LUNG)815,0000-815,000$5.53M$0—-$5.53M
Quoin Pharmaceuticals LtdADS282,2490-282,249$183.7K$0—-$183.7K
ResMed Inc.(RMD)26,0000-26,000$5.95M$0—-$5.95M
Revolution Medicines, Inc.(RVMD)60,0000-60,000$2.62M$0—-$2.62M
RxSight, Inc.(RXST)285,0000-285,000$9.80M$0—-$9.80M
Sarepta Therapeutics, Inc.(SRPT)127,0000-127,000$15.44M$0—-$15.44M
Savara Inc.(SVRA)1,579,0000-1,579,000$4.85M$0—-$4.85M
Soleno Therapeutics Inc250,0000-250,000$11.24M$0—-$11.24M
Syndax Pharmaceuticals, Inc.(SNDX)370,0000-370,000$4.89M$0—-$4.89M
Terns Pharmaceuticals Inc475,0000-475,000$2.63M$0—-$2.63M
TG Therapeutics, Inc.(TGTX)95,0000-95,000$2.86M$0—-$2.86M
Unicycive Therapeutics Inc1,473,0000-1,473,000$1.17M$0—-$1.17M
Vera Therapeutics, Inc.CL A(VERA)432,0000-432,000$18.27M$0—-$18.27M
Veru Inc.(VERU)2,028,5340-2,028,534$1.32M$0—-$1.32M
Viking Therapeutics, Inc.(VKTX)146,0000-146,000$5.88M$0—-$5.88M
Page 1 of 1
Altium Capital Management LLC — 13F Holdings — Q1 2025 | TickerTrail